 WAKEFIELD, Mass., April 14, 2021 GLOBE NEWSWIRE -- Innovation Pharmaceuticals OTCQB:IPIX the Company, a clinical stage biopharmaceutical company, today announced that Brilacidin, the Companys defensin-mimetic drug candidate, was featured in the Mason Science Series: Rising to the National and International COVID-19 Challenge, a presentation of George Mason University. 